Dementia Antipsychotics And Antidepressants Discontinuation Study

• Status: Completed
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to discontinue antipsychotics and antidepressants, and to study its effect on Behavioural- and Psychological Symptoms in Dementia (BPSD).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sykehuset Innlandet HF
• Collaborators: Alesund Hospital; Bjørgene Omsorgssenter, Haugesund; Diakonhjemmet Hospital; Eikertun Nursing Home; Innlandet Hospital Trust, Reinsvoll; Innlandet Hospital Trust, Sanderud; Kløveråsen, Bodø; Kroken Nursing Home, Tromsø; Songdalstunet Nursing Home; Sykehuset Buskerud HF; Sykehuset Telemark; The Nordmøre and Romsdal Hospital Trust; Ullevaal University Hospital; University of Bergen
• Treatments: Antidepressive Agents; Antipsychotic Agents; Citalopram; Paroxetine; Risperidone; Sertraline

Criteria

Inclusion Criteria:

• Vascular- or Alzheimer Dementia

• Nursing Homes resident for 3 months or more

• Given antipsychotics or antidepressants for 3 months or more

• Clinical Dementia rating 1, 2 or 3

Exclusion Criteria:

• Dementia of other origin

• Psychiatric disease

• Life expectancy less than 3 months

• Acute infection last 10 days

• Unstable Diabetes Mellitus

• Terminal disease